Literature DB >> 4547138

Anti-tumour activity of aprotinin.

A L Latner, E Longstaff, G A Turner.   

Abstract

A malignant invasive fibrosarcoma in hamsters and a malignant mammary carcinoma in mice were each challenged with the broad spectrum proteinase inhibitor aprotinin (Trasylol). In both tumour systems, significant anti-tumour effects of aprotinin were observed. Variations in the site and dosage of aprotinin application were made in an attempt to improve the chemotherapeutic response.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4547138      PMCID: PMC2009194          DOI: 10.1038/bjc.1974.113

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  Increase of lysosomal enzymes in skin cancers.

Authors:  R J Shamberger; G Rudolph
Journal:  Nature       Date:  1967-02-11       Impact factor: 49.962

2.  Effect of collagenolytic activity in basal cell epithelioma of the skin on reconstituted collagen and physical properties and kinetics of the crude enzyme.

Authors:  Y Yamanishi; M K Dabbous; K Hashimoto
Journal:  Cancer Res       Date:  1972-11       Impact factor: 12.701

3.  Collagenolytic activity of sarcoma tissues in culture.

Authors:  A C Taylor; B M Levy; J W Simpson
Journal:  Nature       Date:  1970-10-24       Impact factor: 49.962

4.  Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes.

Authors:  M Hozumi; M Ogawa; T Sugimura; T Takeuchi; H Umezawa
Journal:  Cancer Res       Date:  1972-08       Impact factor: 12.701

5.  Proteolytic enzymes initiating cell division and escape from contact inhibition of growth.

Authors:  M M Burger
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

6.  Tumorigenesis in mouse skin: inhibition by synthetic inhibitors of proteases.

Authors:  W Troll; A Klassen; A Janoff
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

7.  Release from density dependent growth inhibition by proteolytic enzymes.

Authors:  B M Sefton; H Rubin
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

8.  Collagenolytic enzymes in human neoplasms.

Authors:  M H Dresden; S A Heilman; J D Schmidt
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

9.  Effects of protease inhibitors on growth of hamster tumor cells in culture.

Authors:  I E Goetz; C Weinstein; E Roberts
Journal:  Cancer Res       Date:  1972-11       Impact factor: 12.701

10.  Enhanced malignant behaviour of cells treated with crude rat liver histone.

Authors:  A L Latner; E Longstaff; G A Turner
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

View more
  16 in total

1.  The influence of the protease inhibitor aprotinin on tumor invasion of three cell lines in vitro.

Authors:  E Prange; W Schroyens; H Pralle
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  The in vitro effect of aprotinin upon spleen cells from normal and tumour-bearing mice exposed to PPD and tumour cells.

Authors:  J G Freeman; A L Latner; G A Turner; C W Venables
Journal:  Experientia       Date:  1980-02-15

3.  Enhancement of mechanisms acting against mammary carcinoma: pancreatic trypsin inhibitor.

Authors:  A A Hakim
Journal:  Klin Wochenschr       Date:  1978-08-01

4.  Growth regulators in connective tissue. Systemic administration of an aortic extract inhibits tumor growth in mice.

Authors:  R Eisenstein; B Schumacher; C Meineke; B Matijevitch; K E Kuettner
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

5.  Post operative stimulation of cell mediated immunity.

Authors:  J A Smith; W S Hendry; J L Duncan; J N Norman
Journal:  Klin Wochenschr       Date:  1985-10-01

6.  Serum activities of lysosomal enzymes in patients with liver cell carcinoma.

Authors:  N Nagasue; K Inokuchi; R Kanashima
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

7.  A possible association between aprotinin and improved survival after radical surgery for mesothelioma.

Authors:  Peter H Norman; Peter F Thall; Ronaldo V Purugganan; Bernhard J C J Riedel; Dilip R Thakar; David C Rice; Lisa Huynh; Wei Qiao; Sijin Wen; W Roy Smythe
Journal:  Cancer       Date:  2009-02-15       Impact factor: 6.860

Review 8.  Clinical trials with anticoagulant and antiplatelet therapies.

Authors:  L R Zacharski; K R Meehan; S M Algarra; F A Calvo
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 9.  Cell detachment and metastasis.

Authors:  L Weiss; P M Ward
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Present status and upcoming prospects of hedgehog pathway inhibitors in small cell lung cancer therapy.

Authors:  Syed Hassan Abbas Naqvi; Syed Hassan Shiraz Naqvi; Muhammad Yasin Bandukda; Syed Mumtaz Ali Naqvi
Journal:  Infect Agent Cancer       Date:  2013-05-22       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.